These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7545499)

  • 1. Antigen-specific immunodeficiency and its relation to the spectrum of American cutaneous leishmaniasis.
    Convit J; Ulrich M
    Biol Res; 1993; 26(1-2):159-66. PubMed ID: 7545499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunopathology of American tegumentary leishmaniasis].
    Castés M; Tapia FJ
    Acta Cient Venez; 1998; 49(1):42-56. PubMed ID: 10205916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical and immunological spectrum of American cutaneous leishmaniasis.
    Convit J; Ulrich M; Fernández CT; Tapia FJ; Cáceres-Dittmar G; Castés M; Rondón AJ
    Trans R Soc Trop Med Hyg; 1993; 87(4):444-8. PubMed ID: 8249076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
    Coutinho SG; Oliveira MP; Da-Cruz AM; De Luca PM; Mendonça SC; Bertho AL; Soong L; McMahon-Pratt D
    Exp Parasitol; 1996 Nov; 84(2):144-55. PubMed ID: 8932764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential interferon- gamma production characterizes the cytokine responses to Leishmania and Mycobacterium leprae antigens in concomitant mucocutaneous leishmaniasis and lepromatous leprosy.
    Matos DS; Azeredo-Coutinho RB; Schubach A; Conceição-Silva F; Baptista C; Moreira JS; Mendonça SC
    Clin Infect Dis; 2005 Jan; 40(2):e5-12. PubMed ID: 15655736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of tumor necrosis factor in patients with American cutaneous leishmaniasis.
    Castes M; Trujillo D; Rojas ME; Fernandez CT; Araya L; Cabrera M; Blackwell J; Convit J
    Biol Res; 1993; 26(1-2):233-8. PubMed ID: 7670536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral immune responses among mucosal and cutaneous leishmaniasis patients caused by Leishmania braziliensis.
    Valli LC; Passos VM; Dietze R; Callahan HL; Berman JD; Grogl M
    J Parasitol; 1999 Dec; 85(6):1076-83. PubMed ID: 10647040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cutaneous lesion in American leishmaniasis: leukocyte subsets, cellular interaction and cytokine production.
    Tapia FJ; Caceres-Dittmar G; Sanchez MA; Fernandez AE; Convit J
    Biol Res; 1993; 26(1-2):239-47. PubMed ID: 7545501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
    Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms associated with immunoregulation in human American cutaneous leishmaniasis.
    Castés M; Agnelli A; Rondón AJ
    Clin Exp Immunol; 1984 Aug; 57(2):279-86. PubMed ID: 6467674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy with live BCG plus heat killed Leishmania induces a T helper 1-like response in American cutaneous leishmaniasis patients.
    Cabrera M; Blackwell JM; Castes M; Trujillo D; Convit J; Shaw MA
    Parasite Immunol; 2000 Feb; 22(2):73-9. PubMed ID: 10652119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo evaluation of immune responses in leishmaniasis: the use of cross-species leishmanin preparations for skin testing.
    Akuffo H; Darce M; Maasho K; Berhan TY
    Am J Trop Med Hyg; 1995 Jul; 53(1):16-22. PubMed ID: 7625529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic responsiveness in American cutaneous leishmaniasis lesions.
    Pirmez C; Cooper C; Paes-Oliveira M; Schubach A; Torigian VK; Modlin RL
    J Immunol; 1990 Nov; 145(9):3100-4. PubMed ID: 1976709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific inhibition of lymphocyte-proliferation responses by adherent suppressor cells in diffuse cutaneous leishmaniasis.
    Petersen EA; Neva FA; Oster CN; Bogaert Diaz H
    N Engl J Med; 1982 Feb; 306(7):387-92. PubMed ID: 6460184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. American tegumentary leishmaniasis: a quantitative analysis of Langerhans cells presents important differences between L. (L.) amazonensis and Viannia subgenus.
    Xavier MB; Silveira FT; Demachki S; Ferreira MM; do Nascimento JL
    Acta Trop; 2005 Jul; 95(1):67-73. PubMed ID: 15935321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-gamma production.
    Castellano LR; Filho DC; Argiro L; Dessein H; Prata A; Dessein A; Rodrigues V
    Hum Immunol; 2009 Jun; 70(6):383-90. PubMed ID: 19480861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of vaccination with a combination of Leishmania amastigote antigens and the lipid A-analogue ONO-4007 for immunoprophylaxis and immunotherapy against Leishmania amazonensis infection in a murine model of New World cutaneous leishmaniasis.
    Calvopina M; Barroso PA; Marco JD; Korenaga M; Cooper PJ; Nonaka S; Hashiguchi Y
    Vaccine; 2006 Jul; 24(27-28):5645-52. PubMed ID: 16621179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential recognition of Leishmania aethiopica antigens by lymphocytes from patients with local and diffuse cutaneous leishmaniasis. Evidence for antigen-induced immune suppression.
    Akuffo HO; Fehniger TE; Britton S
    J Immunol; 1988 Oct; 141(7):2461-6. PubMed ID: 3171177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell mediated immunity in American cutaneous and mucosal leishmaniasis.
    Carvalho EM; Johnson WD; Barreto E; Marsden PD; Costa JL; Reed S; Rocha H
    J Immunol; 1985 Dec; 135(6):4144-8. PubMed ID: 4067312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy as a treatment of American cutaneous leishmaniasis: preliminary studies in Brazil.
    Mayrink W; Magalhaes PA; Michalick MS; da Costa CA; Lima Ade O; Melo MN; Toledo VP; Nascimento E; Dias M; Genaro O
    Parassitologia; 1992 Dec; 34(1-3):159-65. PubMed ID: 1339971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.